000			01630pam a2200397 i 4500
999			_c35742 _d35742
001			9916374113406676
003			TH-BaNU
005			20220909114827.0
008			211104s2014 caua b 001 0 eng
010			_a 2013043146
020			_a9780123820303 (alk. paper)
020			_a0123820308 (alk. paper)
040			_aDLC _beng _erda _cDLC _dYDXCP _dIMN _dTH-BaNU
041	0		_aeng
042			_apcc _anlmcopyc
060	0	0	_aQV 744 _bS55 2014
100	1		_aSilverman, Richard B., _eauthor.
245	1	4	_aThe organic chemistry of drug design and drug action / _cRichard B. Silverman, Mark W. Holladay.
250			_aThird edition.
264		1	_aSan Diego, CA : _bElsevier/Academic Press, _c2014
300			_axviii, 517 pages : _billustrations (some color) ; _c29 cm
336			_atext _2rdacontent
337			_aunmediated _2rdamedia
338			_avolume _2rdacarrier
504			_aIncludes bibliographical references and index.
505	0		_aIntroduction -- Lead discovery and lead modification -- Receptors -- Enzymes -- Enzyme inhibition and inactivation -- Dna-interactive agents -- Drug resistance and drug synergism -- Drug metabolism -- Prodrugs and drug delivery systems.
650	1	2	_aChemistry, Pharmaceutical _0https://id.nlm.nih.gov/mesh/D002626
650	2	2	_aChemistry, Organic _0https://id.nlm.nih.gov/mesh/D002625
650	2	2	_aDrug Design _0https://id.nlm.nih.gov/mesh/D015195
650	2	2	_aPharmacokinetics _0https://id.nlm.nih.gov/mesh/D010599
700	1		_aHolladay, Mark W., _eauthor.
850			_aKCNL
942			_2nlm _cGB _01
998			_cnuch